JMIR Publications

ABSTRACT

As the cost of clinical trials continues to rise, novel approaches are required to ensure an ethical allocation of resources. Multisite trials have been increasingly utilized in Phase 1 trials for rare diseases as well as in Phase 2 and 3 trials to meet accrual needs. The benefits of multisite trials include easier patient recruitment, expanded generalizability, and more robust statistical analyses. However, there are several problems more likely to arise in multisite trials including accrual inequality, protocol non-adherence, data entry mistakes, and data integration difficulties. The Biostatistics & Data Science department at the University of Kansas Medical Center developed a Clinical Trial Management System (Comprehensive Research Information System or CRIS) specifically designed to streamline multisite clinical trial management. An NICHD funded Phase 3 trial, The Assessment of DHA on Reducing Early Preterm Birth (ADORE) fully utilized CRIS to provide automated accrual reports, centralize data capture, automate trial completion reports, and streamline data harmonization. Using ADORE as an example, we describe the utility of CRIS in database design, regulatory compliance, training standardization, study management, and automated reporting. Our goal is to continue to build CRIS through use in subsequent multisite trials. Reports generated to suit the needs of future studies will be available as templates. The implementation of similar tools and systems could provide significant cost saving and operational benefit to multisite trials.